vers la météo de la validation par utilisateur

Ingenuity256

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 27 - PMID ?

In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :
Analyse 0 
                                                           +-----------------------------------COMP:V-N(after)----------------------------------+      
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                                   +---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)
Analyse 1 
                                                           +-----------------------------------COMP:V-N(after)----------------------------------+      
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                                   +---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)
Analyse 2 
                                                           +-----------------------------------COMP:V-N(after)----------------------------------+      
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                                   +---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)
Analyse 3 
                                                           +-----------------------------------COMP:V-N(after)----------------------------------+      
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                                   +---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)
Analyse 4 
                                                           +-----------------------------------COMP:V-N(after)----------------------------------+      
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                               |      
      |                +-----------COMP:V-N(from)----------+---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)
Analyse 5 
                                                           +-----------------------------------COMP:V-N(after)----------------------------------+      
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                               |      
      |                +-----------COMP:V-N(from)----------+---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)
Analyse 6 
                                                           +-----------------------------------COMP:V-N(after)----------------------------------+      
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                               |      
      |                +-----------COMP:V-N(from)----------+---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)
Analyse 7 
                                                           +-----------------------------------COMP:V-N(after)----------------------------------+      
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                               |      
      |                +-----------COMP:V-N(from)----------+---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)
Analyse 8 
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+                                   +---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)
Analyse 9 
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+                                   +---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)
Analyse 10 
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+                                   +---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)
Analyse 11 
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+                                   +---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)
Analyse 12 
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                                      
      |                +-----------COMP:V-N(from)----------+---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)
Analyse 13 
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                                      
      |                +-----------COMP:V-N(from)----------+---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)
Analyse 14 
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                                      
      |                +-----------COMP:V-N(from)----------+---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)
Analyse 15 
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                                      
      |                +-----------COMP:V-N(from)----------+---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)
Analyse 16 
                                                                                    +----------------------COMP:N-N(after)----------------------+      
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                                   +---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)
Analyse 17 
                                                                                    +----------------------COMP:N-N(after)----------------------+      
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                                   +---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)
Analyse 18 
                                                                                    +----------------------COMP:N-N(after)----------------------+      
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                                   +---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)
Analyse 19 
                                                                                    +----------------------COMP:N-N(after)----------------------+      
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                                   +---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)
Analyse 20 
                                                                                    +----------------------COMP:N-N(after)----------------------+      
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                               |      
      |                +-----------COMP:V-N(from)----------+---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)
Analyse 21 
                                                                                    +----------------------COMP:N-N(after)----------------------+      
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                               |      
      |                +-----------COMP:V-N(from)----------+---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)
Analyse 22 
                                                                                    +----------------------COMP:N-N(after)----------------------+      
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                               |      
      |                +-----------COMP:V-N(from)----------+---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)
Analyse 23 
                                                                                    +----------------------COMP:N-N(after)----------------------+      
      +--------------------COMP:V-N(In)--------------------+                        +--------COMP:N-N(of)-------+                               |      
      |                +-----------COMP:V-N(from)----------+---------OBJ:V-N--------+           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+               +MOD_ATT:N-AD+SUBJ:V+COMP:V-N(b+             |           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |               |            |      |          |             |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ , tetradecylthioacetic acid increases ( by 8 fold ) expression of __SP__ __NODE__ mRNA(s) 12 weeks after initial treatment .
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (acid,tetradecylthioacetic)
COMP:V-N(In) (increase,liver)
COMP:V-N(from) (increase,__SP__)
SUBJ:V-N (increase,acid)
COMP:V-N(by) (increase,8)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (week,@card@)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)